Pancreatic Cancer Research

ResearcherResearch Inst Of Fox Chase Can CtrActive in the last 2 years

Igor Astsaturov

Verified by NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on NIH RePORTER profile ID 10639342. Sources: NIH RePORTER.

Their work

Papers
0
Trials
0
Grants
5
Labs led
1
Collaborators
4
Papers, trials and grants by year

2018: 1 grant · 2019: none · 2020: 1 grant · 2021: none · 2022: 1 grant · 2023: none · 2024: none · 2025: 1 grant · 2026: 1 grant

Grants 5

  1. Targeting anoctamin 6 to disrupt trogocytosis of cancer-associated fibroblasts R01CA289629↗
  2. Divergent Functions of ERK2 Substrate Binding Domains in Pathogenesis of KRAS-Driven Pancreatic Cancer R03CA286669↗
  3. Neoadjuvant Stroma Modification in Pancreatic Cancer R21CA252535↗
  4. Oncogenic Synapses: cell-cell contacts enabling trogocytic-based metabolic interactions between pancreatic cancer and fibroblastic stromal cells R21CA231252↗
  5. Synergistic targeting of cholesterol metabolism and EGFR signaling in cancer R01CA188430↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jonathan A Soboloff · 1 shared grant, 2026 · strength 1.26
  2. David L. Wiest · 1 shared grant, 2025 · strength 1.07
  3. Efrat Dotan · 1 shared grant, 2022 · strength 0.66
  4. Edna Cukierman · 1 shared grant, 2020 · strength 0.48

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.